Tarcísio Cícero de Lima Araújo

Tarcísio Cícero de Lima Araújo

Auto-generated profile, based on publicly available information

Tarcísio Cícero de Lima Araújo

CENTRO UNIVERSITÁRIO MAURÍCIO DE NASSAU (UNINASSAU)

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
DRDalila de Brito Marques Ramos
Dalila de Brito Marques Ramos
MAMaria Taís de Moura Fontes Araújo
Maria Taís de Moura Fontes Araújo
TATarcísio Cícero de Lima Araújo
Tarcísio Cícero de Lima Araújo
ONOsmar Galvão dos Santos Neto
Osmar Galvão dos Santos Neto
MSMariana Gama e Silva
Mariana Gama e Silva
Thiago Henrique NapoleãoThiago Henrique Napoleão
Thiago Henrique Napoleão

25 October 2019 in Recent Patents on Biotechnology
Verified
Journal Article
Closed access
PDF file
PMPedro Menezes
Pedro Menezes
EPEmanuella Chiara Valença Pereira
Emanuella Chiara Valença Pereira
MSMaria Eduarda Gomes da Cruz Silva
Maria Eduarda Gomes da Cruz Silva
BSBismarques Augusto Oliveira da Silva
Bismarques Augusto Oliveira da Silva
LFLuiz Antonio Miranda de Souza Duarte Filho
Luiz Antonio Miranda de Souza Duarte Filho
LRLarissa Araújo Rolim
Larissa Araújo Rolim
Background: The inflammatory process is a physiological response to a vast number of harmful stimulus that takes place in order to restore homeostasis. Many drugs used in pharmacotherapy are effective to control inflammatory responses, however, there is a range of adverse effects attributed to steroidal and non-steroidal anti-inflammatory drugs (NSAIDs). In this sense, herbal medicine and derivatives have gained more attention because of their effectiveness and safety, showing the importance of medicinal plants, especially the Cannabis genus and the cannabinoid derivatives.Objective: The aim of this prospection was to identify data related to patents involving Cannabis and cannabinoids for the treatment of inflammation.Method: To do so, a search for patents was conducted to evaluate the anti-inflammatory activity of Cannabis and cannabinoids. Four specialized databases for patent research were consulted using the terms "cannabis", "cannabidiol", "cannabinoids" and "THC" associated with "inflammation".Results: A total of 370 patents were found, of which 17 patents met the inclusion criteria. Although reports show synergistic effects of the plant components, patents involving Cannabis and cannabinoids focus on isolated substances (CBD e THC).Conclusion: However, patents related to Cannabis and cannabinoids are promising for future use of the plant or its derivatives on the treatment of inflammation.

8 July 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
TATarcísio Cícero de Lima Araújo
Tarcísio Cícero de Lima Araújo
PMPedro Menezes
Pedro Menezes
TRTiago Feitosa Ribeiro
Tiago Feitosa Ribeiro
CMCícero André Ferreira Macêdo
Cícero André Ferreira Macêdo
NSNathália Andrezza Carvalho de Souza
Nathália Andrezza Carvalho de Souza
LRLarissa Rolim
Larissa Rolim

23 September 2025 in Chemistry & Biodiversity
Verified
Journal Article
Open access
NSNathália Andrezza Carvalho de Souza
Nathália Andrezza Carvalho de Souza
PSPedro Guilherme Sousa de Sá
Pedro Guilherme Sousa de Sá
TATarcísio Cícero de Lima Araújo
Tarcísio Cícero de Lima Araújo
VSVictória Laysna dos Anjos Santos
Victória Laysna dos Anjos Santos
GNGuilherme Urias Menezes Novaes
Guilherme Urias Menezes Novaes
LRLarissa Rolim
Larissa Rolim
Mimosa tenuiflora (Willd.) Poir., known as “Jurema‐preta”, is a species of ethnobotanical relevance, used in traditional medicine. The northeastern backland is characterized by climatic variability, which makes it essential to carry out studies that assess the seasonal influence on the chemical profile of native species. The aim of this study was to evaluate the seasonal variation in the chemical constituents of M. tenuiflora over a 24‐month period. Plant collections were made bimonthly in the municipality of Petrolina, Pernambuco, Brazil. The plant material was dried, pulverized, and extracted with ethanol (1:10, w/v) for 72 h under magnetic stirring. The analyses included the quantification of secondary metabolites, the development of a method using high‐performance liquid chromatography with a diode array detector for the quantification of N,N ‐dimethyltryptamine (DMT), and multivariate statistical analysis using principal component analysis. The results indicated that phenolic compounds, especially flavonoids, are associated with water stress, radiation, and temperature. DMT production showed a negative correlation with radiation and temperature, but not with precipitation. Total alkaloids and yield showed little correlation with climatic variables. This study reinforces the importance of seasonality in the planning of plant collection and the pharmacological use of M. tenuiflora . M. tenuiflora , “Jurema preta”, seasonality, HPLC‐DAD, PCA

15 June 2018 in Revista Gestão Inovação e Tecnologias
Verified
Journal Article
Open access
PDF file
PSPedrita Alves Sampaio
Pedrita Alves Sampaio
JFJosé Marcos Teixeira de Alencar Filho
José Marcos Teixeira de Alencar Filho
NSN. A. C. Souza
N. A. C. Souza
HTHyany Andreysa Pereira Teixeira
Hyany Andreysa Pereira Teixeira
TATarcísio Cícero de Lima Araújo
Tarcísio Cícero de Lima Araújo
LRLarissa Rolim
Larissa Rolim
Technological prospection of Morus nigra L.

24 October 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
JFJosé Marcos Teixeira de Alencar Filho
José Marcos Teixeira de Alencar Filho
AFAna Rita de Sousa França
Ana Rita de Sousa França
LSLuana Beatriz Silva
Luana Beatriz Silva
PSPedrita Alves Sampaio
Pedrita Alves Sampaio
EPEmanuella Chiara Valença Pereira
Emanuella Chiara Valença Pereira
LRLarissa Rolim
Larissa Rolim
Background/Objectives: Primary dysmenorrhea is a prevalent condition that causes severe uterine cramps in women worldwide. The objective of this work was to synthesize and characterize a novel immediate-release system using vitexin and ZIF-8, and to evaluate its pharmacological action in a model of primary dysmenorrhea. Methods: A 22 full factorial design guided the synthesis of the system. Physicochemical characterization was performed by FT-IR, TG, DSC, SEM, XRD, and in vitro release tests. Pharmacological activity was assessed in an oxytocin-induced dysmenorrhea model in mice. In addition, in silico molecular docking and molecular dynamics simulations were conducted to explore the potential mechanism of action of vitexin. Results: Optimal yield and loading capacity were achieved at the high levels of the factorial design. Characterization analyses confirmed the successful formation of the vitexin@ZIF-8 (VIT@ZIF-8) system. The release study demonstrated a markedly enhanced dissolution rate of vitexin. Both isolated vitexin and VIT@ZIF-8 reduced abdominal writhing when administered orally at 3 and 30 mg/kg, while intraperitoneal activity was observed only at 30 mg/kg. Computational analyses revealed favorable interactions of vitexin with aldose reductase (AKR1C3), suggesting this enzyme as a potential molecular target in dysmenorrhea. Conclusions: The VIT@ZIF-8 system represents a promising strategy to improve the dissolution profile of vitexin, although pharmacological activity in this model was not superior to the isolated compound. The combined in vivo and in silico evidence supports vitexin as a potential antidysmenorrheic agent, possibly through modulation of AKR1C3. These findings open avenues for future studies addressing the molecular pathways of vitexin and for the development of novel therapeutic approaches for primary dysmenorrhea.